In breast cancer, histone alteration may be a systematic mechanism of TXNIP transcriptional regulation, as evidenced by the rapid development of TXNIP mRNA in breast cancer cell lines which was seen when a histone deacetylase inhibitor was used to improve acetylation. This evidence concerns the gene TXNIP and breast cancer.